Filing Details

Accession Number:
0001104659-14-006737
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-05 15:38:45
Reporting Period:
2014-02-04
Filing Date:
2014-02-05
Accepted Time:
2014-02-05 15:38:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS Pharmaceutical Preparations (2834) 264738379
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1121404 Sanofi 54 Rue La Boetie
Paris I0 75008
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $ 0.001 Par Value- Acquisiton 2014-02-04 1,303,780 $7.67 5,053,779 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. Shares are held directly by Aventis Holdings Inc. an indirectly wholly owned subsidiary of Sanofi. Accordingly, Sanofi can be deemed to share voting and dispositive power over the shares held directly by Aventis Holdings Inc.